Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.

Suilane Coelho Ribeiro Oliveira,Camila Motta Venchiarutti Moniz,Rachel P. Riechelmann,Alexandra Kichfy Alex,Maria Ignez Braghirolli,Giovanni M. Bariani,Caio Sergio Rizkallah Nahas,Paulo M. Hoff

Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.

2016

Suilane Coelho Ribeiro Oliveira
Camila Motta Venchiarutti Moniz
Rachel P. Riechelmann
Alexandra Kichfy Alex
Maria Ignez Braghirolli
Giovanni M. Bariani
Caio Sergio Rizkallah Nahas
Paulo M. Hoff

Summary This was a phase II study of capecitabine in substitution of 5-fluorouracil (5-FU) in the chemoradiotherapy regimen for patients with localized squamous cell carcinoma of the anal canal.

Keywords:

Anal canal
General surgery
Fluorouracil
Carcinoma
Regimen
Capecitabine
Phases of clinical research
Chemoradiotherapy
Medicine
Survival rate
Radiation therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations